Lectures by Invitation

6/24/201913th International Conference on Pathways, Networks, and Systems Medicine, Chania, Crete, Greece. An update on the clinical development of compstatin-based drug candidate AMY-101.
6/13/201912th International Conference on Complement Therapeutics,  Rhodes, Greece. An update on the clinical development of the compstatin-based drug candidate AMY-101.
5/17/2019The New Era of Aplastic Anemia and Paroxysmal Noctrunal Hemoglobinuria, Napoli, Italy. Anti-C3: AMY-101 and other compstatins.
8/29/2018
University Hospital, University of Sao Paulo, Ribeirao Preto, Brazil. Innate immunity: More than a guard against invading pathogens.
8/28/2018
Butantan Institute, Sao Paulo, Brazil. Innate immunity: More than a guard against invading pathogens.
7/24/201811th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the clinical development of compstatin (AMY-101). 
3/10/2018
University of Athens Medical School, Department of Pathology-Nephrology. Complement therapeutics.
9/11/2017University of Malmo, Malmo, Sweden. Development of pharmacological interventions against complement factor C3 and potential indications in renal medicine and transplantation.
9/8/2017
C3G Satellite Meeting, Copenhagen, Denmark. Targeting C3.
9/6/2017
University of Ulm, Ulm, Germany. News in the world of complement research.
6/30/201712th International Conference on Pathways, Networks, and Systems Medicine, Heraklion, Crete, Greece. Status of complement therapeutics.
6/27/201710th International Conference on Complement Therapeutics. Compstatin Cp40 (AMY101): A C3 complement inhibitor reaching its prime for bedside intervention, Heraklion, Crete, Greece.
6/21/201714th International Conference on Innate Immunity, Heraklion, Crete, Greece. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight.
9/30/20162nd International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
6/29/20169th International Conference on Complement Therapeutics, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
6/25/201613th International Conference on Innate Immunity, Ixia, Rhodes, Greece. Compastatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
11/18/2015IPITA, IXA, CTS Joint Congress, Melbourne, Australia. New reagents to regulate complement activation.
9/2/2015
8th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the preclinical and clinical development of the therapeutic C3 inhibitor Cp40.
8/11/201512th World Congress on Inflammation, Boston, MA, USA. Compstatin CP40: An immune modulator on a journey from disease models to clinical development.
8/9/2015
12th World Congress on Inflammation, Boston, MA, USA. Complement: More than a "guard" against pathogens.
6/21/201512th International Conference on Innate Immunity, Chania, Crete, Greece. Compstatin Cp40: An immune modulator on a journey from disease models to clinical development.
5/3/2015
State of the Art Speaker, American Transplantation Conference, Philadelphia, PA, USA.  Complement: More Than a "guard" against pathogens.
1/9/2015
University of Florence, Italy. Complement: More than a "guard" against pathogens.
9/29/2014
1st International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Chania, Crete, Greece. Cp40: A complement inhibitor getting ready for primetime.
6/5/2014
11th International Conference on Innate Immunity, Olympia, Greece. Complement C3 ihibitors getting ready for primetime: Compstatin Cp40 in local and systemic applications.
5/22/2014Linneaus University Center for Biomaterials Chemistry, Kalmar, Sweden. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight.
4/9/2014
Institute for Systemic Inflammation Research, Luebeck University, Luebeck, Germany. Innate immunity: More than a guard against invading pathogens.
3/27/2014Aplastic Anemia & MDS International Foundation. Bone Marrow Failure Disease Scientific Symposium, Rockville, MD. Rational and preclinical development of novel strategy of complement inhibition.
8/25/201315th International Congress of Immunology, Milan, Italy.  The renaissance of complement.
6/27/201310th International Conference on Innate Immunity, Kos, Greece. Preclinical development of compstatin: Progress, applications, and insight about therapeutic complement inhibition at the level of C3.
6/19/20136th International Conference on Complement Therapeutics, Kos, Greece. Therapeutic complement inhibition at the level of C3: Microconceptions, myths, and novel insight.
1/24/2013Rudbeck Seminar, Uppsala University, Sweden. Innate immunity: More than a guard against invading pathogens.
1/18/2013
15th Rheumatology Scientific Meeting of the Northwestern Greece, Ioannina, Greece. Innate immunity: More than a "guard" against pathogens.
1/17/2013Medical and Dental Societies, Agrinion, Greece. Microbes: Friends or Foes?
1/16/2013EKFE, Arta, Greece. Microbes: Friends or Foes?
1/12/2013Balances: Basic Knowledge and Development in Hematology, Ioannina, Greece. Innate Immunity: Therapeutic approaches with emphasis on hematological diseases.
10/13/2012XXIV International Complement Workshop, Chania, Crete, Greece. Bringing compstatin to the next level: Novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application.
10/8/2012Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, Chania, Crete, Greece. Shifting a paradigm? Unexpected
functions of complement in cancer.
6/26/2012
9th International Conference on Innate Immunity, Rhodes, Greece. Compstatin: A complement inhibitor on its way to clinical application.
6/8/2012
13th Naples Workshop on Bioactive Peptides, Naples, Italy. Peptide based complement inhibitors: From bench to bedside.
2/21/2012
Sanquin Blood Supply Foundation, Dept. of Immunopathology, Amsterdam, The Netherlands. Innate immunity: More than a "guard" against invading pathogens
11/8/2011State of the Art lecture, ACR/ARHP Annual Scientific Meeting, Chicago. Complementary roles for complement in rheumatic diseases.
10/26/2011
Dept. di Biochimica e Biotecnologie Mediche, Dept. Assistenziale di Clinica Medica, Universita di Napoli Federico II. Innate immunity: More than a "guard" against invading pathogens.
10/25/2011Instituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Naples, Italy. Structure and function of complement proteins and design of complement inhibitors.
10/21/2011Department of Medicine, Division of Allergy and Immunology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens.
10/6/2011Department of Ophthalmology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens.
10/5/2011Center for Research on Reproduction and Women's Health, University of Pennsylvania Perelman School of Medicine. Innate immunity: More than a "guard" against invading pathogens.
9/14/2011
4th International Conference on Crossroads between Innate and Adaptive Immunity, Mykonos, Greece. A keystone biological system for immune surveillance and homeostasis.
6/23/20115th International Complement Therapeutics Conference, Rhodes, Greece. An update on compstatin.
6/17/20118th International Innate Immunity Workshop, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens.
6/14/2011
9th International Conference on Pathways, Networks and Systems Medicine, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens.
4/8/2011
City University of Hong Kong. Innate immunity: More than a "guard" against invading pathogens.
3/4/2011
Systems Biology Institute, Seattle. Innate immunity: More than a "guard" against invading pathogens.
1/19/2011The University of Chicago, Committee on Microbiology Seminar Series. The renaissance of complement.
12/2/2010Department of Molecular Microbiology and Immunology, Brown University. The renaissance of complement.
10/2/20101st Biennial Symposium on AMD, Harvard Medical School, Boston. Complement therapeutics.
9/16/2010
Somalogic, Boulder, Colorado. A "multidisciplinary" approach to understand disease and pathogenesis and develop therapeutics.
3/29/2010
3rd Joint Conference of the German Society for Hygiene and Microbiology (DGHM) e.V. and the Association for General and Applied Microbiology (VAAM), Hanover, Germany. The renaissance of complement.
11/28/2009
1st International Conference on Molecular Cancer Research, Athens, Greece. Shifting the paradigm. Unexpected functions of complement in cancer.
11/27/2009
National Academy of Athens, Greece. Innate immunity.
11/11/2009University of Michigan, Department of Pathology. The renaissance of complement.
10/27/2008Department of Pathology and Laboratory Medicine, University of Pennsylvania. System biology approaches to disease pathogenesis and development of therapeutics.
1/18/2008 Division of Allergy and Immunology, University of Pennsylvania. Complement therapeutics.
10/26/2007
Durham, NC. 1st Annual DIRECT Dry AMD Meeting.  Complement biology and biochemistry.
10/19/2007Department of Neurology Thomas Jefferson University. Systems approaches to disease pathogenesis and development of therapeutics.
9/25/2007
Department of Crystal and Structural Chemistry, Bijvoet Centre for Bimolecular Research, Utrecht University. The structures and functions of the complement system.
6/24/20075th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Porto Heli, Greece. Systems approaches to disease pathogenesis and development of therapeutics.
6/13/20074th Workshop on Complement Associated Diseases, Animal Models, and Therapeutics,Porto Heli, Greece. Novel complement therapeutics.
6/5/2007
4th International Leukocyte Signal Transduction Workshop: Clinical implications of signaling pathways, Rhodes, Greece. Systems approaches to disease pathogenesis and development of therapeutics. 
4/23/20072nd Biosciences Congress, University of Patras, Greece. Plenary lecture on "The today’s challenges in biosciences."
4/19/200741st Annual Scientific Meeting of the European Society for Clinical Investigation, Uppsala, Sweden. Interference with complement activation.
2/6/2007
Stem Cell Biology Program, James Graham Brown Cancer Center University of Louisville. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
12/7/2006
Division of Cell Biology and Biophysics, University of Missouri-Kansas City. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
12/5/2006
GTCBio’s - Medicinal Chemistry at the 2nd Modern Drug Discovery & Development, Philadelphia, PA. Complement inhibitors: From bench to bedside.
10/17/20064th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Mykonos, Greece. A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.
6/30/2006
1st International Conference on Ovarian Cancer: State of the Art and Future Directions, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.
6/7/2006
4th Innate Immunity Conference, Corfu, Greece. Protein-protein interactions in the complement system and development of complement therapeutics.
5/11/2006
University of Kalmar, Sweden. The today’s challenges in biosciences.
5/8/2006
Department of Clinical Immunology, University of Uppsala, Sweden. A "multidisciplinary" approach to today’s challenges in biosciences.
3/15/2006Department of Chemical Engineering and Materials Science, University of Minnesota. Rational design of complement therapeutics.
10/11/2005Grossroads between Innate and Adaptive Immunity, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm.
10/4/2005
3rd International Conference on Pathways, Networks and Systems: Theory and Experiments, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm.
9/10/200513th Signal and Signal Processing in the Immune System. EFIS Conference, Balatonöszöd, Hungary. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
6/7/20053rd Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Rhodes, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/31/2005
3rd Lymphocyte Signal Transduction Workshop, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/25/20052nd International Conference on Tissue Engineering, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. 
5/20/2005
BIOMED Seminar, Engineering School Drexel University. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/12/2005FOCIS, Boston, MA. A multidisciplinary approach to complement functions.
3/17/2005
Philadelphia's Science Center. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences.
3/9/2005
Department of Immunology, Beijing Medical School, China. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences.
1/31/2005
Computer Science Department, School of Computer Science, Carnegie Mellon. From atoms to systems: A multidisciplinary approach to today’s challenges in Biosciences.
12/21/2004Department of Pathology, University of Michigan. A multidisciplinary approach to today’s challenges in biosciences.
12/15/2004
Department of Pathology, School of Dental Medicine, University of Pennsylvania. A "cross-disciplinary" approach to complement mediated functions.
12/12/2004
Department of Pathology, Columbia University. Complement: More than a "guard" against invading pathogens.
9/10/2004
FEBS Immunology Summer Course, Killini, Greece. Complement: More than a "guard" against invading pathogens.
7/14/2004Foundations of Computer Aided Process Design (FOCAPD): Design through product and process design. De novo protein design: An interplay of global optimization, mixed-integer optimization and experiments.
5/3/2004Department of Genetics, Case Western Reserve University, Cleveland, OH. A "multidisciplinary" approach to today’s challenges in biosciences.
4/28/2004Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison. A "multidisciplinary' approach to complement mediated functions.
4/22/20044th Orthopoxvirus Meeting, Washington DC. Vaccinia-host interactions.
3/2/2004
Enrique E. Ecker Memorial Lecture, Case Western Reserve University, Cleveland, OH. From atoms to systems: A "cross-disciplinary" approach to complement mediated functions.
1/22/2004
PENN center for Clinical Immunology, Seminars in Human Translational Immunology. Complement inhibitors: From bench to bedside.
12/8/2003Department of Pathology, University of Pennsylvania. From atoms to systems: A "metadisciplinary" approach to innate immunity.
12/4/2003
NIH/NIEHS Science Retreat on Comparative Systems Biology Approaches as Applied to Environmental Health. A systems biology analysis of innate immunity.
11/28/2003
Departments of Biotechnology/Chemistry/Pharmacology, University of Modena, Italy. From atoms to systems: A "metadisciplinary" approach to innate immunity.
11/24/2003
Division of Rheumatology, University of Pennsylvania. A systems biology analysis of innate immunity.
10/21/2003SOL Sherry Thrombosis Research Center, Temple University. A systems biology analysis of innate immunity.
9/30/2003Aegean Conferences on Pathways, Networks, and Systems: Theory and Experiments, Santorini, Greece. A systems biology analysis of complement functions.
9/16/2003South Jersey ACS Meeting. Rational design of complement inhibitors.
9/9/2003Biochemical Society Focused Meeting, Stevenage, UK. Design of inhibitors for proteolytic cascades. Rational design of complement inhibitors.
8/3/2003Baoding High Tech Developing Zone, China. Design of complement inhibitors.
6/10/200315th European Immunology Congress, Rhodes, Greece. Plenary lecture on Complement: More than a "guard" against invading pathogens.
2/17/2003
Department of Immunology, Beijing Medical School, China. Innate immunity: More than a "guard" against invading pathogens.
2/17/2003
University of Patras, Patras, Greece. Design of complement inhibitors.
2/12/2003University of Ioannina, Ioannina, Greece. Post genomic era challenges.
12/10/2002
Microbiology and Immunology Distinguished Lecture Series, University of Texas Medical Branch, Galveston, TX. Innate immunity: More than a "guard" against invading pathogens.
11/13/2002Exton, PA, 3-Dimentional Pharmaceuticals. Rational design of complement inhibitors.
6/17/200267th Meeting of British Biochemical Society, Cardiff, UK. Rational design of complement inhibitors.
3/27/2002
Department of Microbiology and Immunology, MCP-Drexel. Complement: More than a “guard” against invading pathogens.
10/11/2001International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. Design of complement therapeutics.
10/10/2001
International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. The role of complement in developmental processes.
10/1/2001Perspectives in Tunicate Biology- IV Anton Dohrn Workshop, Ischia, Italy. The role of complement in developmental processes.
6/22/2001The 5th Nordic Symposium on Fish Immunology, Sundvollen, Norway. Structure and functions of trout complement proteins.
2/20/2001
Instituto Tecnologie Biomedichemie, CNR, Rome Italy. Therapeutic interventions in the complement system.
2/16/2001
Stazione Zoologica, Napoli, Italy. The diversity and evolution of innate immunity.
2/2/2001
Immunology Lecture series, Cornell University, Veterinary School, Ithaca, NY. Complement: New horizon.
1/12/2001
ICOS Corporation, Bothell, WA. Protein-protein interactions in the complement system and design of complement inhibitors.
12/6/2000
Pathology Lecture Series. University of Wisconsin-Madison. Protein-protein interactions in the complement system and design of complement inhibitors.
7/10/2000St. George Hospital, Department of Immunology, Allergy & Infectious Diseases, University of New South Wales, Australia. Therapeutic potential of compstatin.
10/25/1999EU Advanced Workshop in Biotechnology- Genome Sequence and Comparative Analysis, Thessaloniki, Greece. High throughput protein analysis: Proteomics and combinatorial chemistry.
10/4/1999
Pharmacology Seminar, Dep. of Pharmacology, Univ. of Pennsylvania, PA. Therapeutic potential of compstatin: A novel complement inhibitor isolated from a phage library.
7/15/1999FASEB Summer Research Conference on Phylogenetic Perspectives on the Vertebrate Immune System. Complement phylogeny and diversity.
4/1/1999
Millennium Biotherapeutics, Boston. Therapeutic potential of compstatin.
11/11/1998Marine Biotechnology Center, University of Maryland Special, Baltimore. Complement diversity.
11/3/1998Division of Hematology & Oncology, CHOP, Philadelphia, PA. Inhibition of complement and cellular activation in whole blood in extracorporeal circulation by Compstatin.
5/23/1998Special Symposium on Biotechology – Athens Greece. The use of combinatorial libraries in the drug discovery process.
5/13/1998
University of Ioannina, Greece. The use of combinatorial libraries in the drug discovery process.
5/7/1998
24th Panhellenic Medical Congress, Athens-Greece. The future xenotransplant.
12/4/1997University of Thessaloniki, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor.
12/2/1997University of Patras, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor.
11/12/1997
University of Oslo, Norway. Therapeutic potential of Compstatin; a novel complement inhibitor.
10/16/1997
IBC’s 3rd Annual Meeting, Washington D.C. Controlling the complement system. Complement inhibitor interfering with C3-ligand interactions.
5/2/1997
Institute of Molecular Medicine, UTC, Huston, TX. Complement and viral molecular mimicry.
10/18/1996
SangStat, Menlo Park, CA. A novel complement inhibitor isolated from a 7 phage-displayed random peptide library.
5/24/1996Amgen Corporation, Boulder, Co. Protein-protein interactions in the complement system and viral molecular mimicry. 
5/23/1996
University of Colorado, Department of Medicine, Denver, Co. Protein-protein interactions in the complement system and viral molecular mimicry.
10/26/1995Children’s Hospital of Philadelphia, Division of Pulmonary Medicine. Molecular interactions in the complement system and viral molecular mimicry.
3/23/1995
Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions in the complement system and viral molecular mimicry. 
3/21/1995Institute Pasteur, Athens, Greece. Protein-protein interactions in the complement system and viral molecular mimicry.
3/20/1995University of Patras, Department of Microbiology. Protein-protein interactions in the complement system and viral molecular mimicry.
12/7/1994
Umea University-Sweden, Medical School. Evasion strategies of microorganisms.
2/8/1994
University of Louisville, Department of Microbiology & Immunology. Structure, functioning and evolution of the third component of complement.
1/19/1994Chiron Co., Emeryville, CA. Critical Care Seminar Series. Design of complement inhibitors.
11/11/1993Alexion Co., New Haven, CT. Protein-protein interactions in the complement system and design of complement inhibitors.
5/24/1993
AAI Meeting, Denver, Co. Phylogenetic analysis of C3.
3/9/1993
Temple University, Department of Microbiology & Immunology. Protein-protein interactions in the complement system.
2/3/1993
University of Pennsylvania, Research Center in Oral Medicine. Protein-protein interactions in the complement system.
12/3/1992 Umea University-Sweden, Medical School. Protein-protein interactions in the complement system.
10/24/1992Fourth International Conference of Anticancer Research, Crete, Greece. Structure and functions of EBV/C3 receptors on human T lymphocytes.
6/5/1992
Washington University (Howard Hughes Scholar), Howard Hughes Medical Institute. Protein-protein interactions in the complement system.
5/16/1992
University of Patras, Department of Microbiology. Evasion Strategies of Microorganisms.
5/14/1992
Second World Conference of the Hellenic Bio-medical Diaspora, Athens, Greece. Structure, functions and phylogeny of C3.
5/11/1992University of Pennsylvania, Division of Laboratory Medicine. Structure and functions of complement proteins.
8/28/199125 Years of Biology in Patras, University of Patras, Department of Biology, Symposium. Structure, functions and phylogeny of the complement system.
3/6/1991
University of Pennsylvania, Department of Pediatrics, Division of Infectious Diseases and Immunology. Evasion Strategies of Microorganisms.
10/23/1990
University of Pennsylvania, Department of Obstetrics and Gynecology. Molecular aspects of the C3 interactions with other complement components and complement receptors.
10/9/1990University of Pennsylvania, Immunology Colloquium. Molecular aspects of the C3 interactions with other complement components and complement receptors.
9/27/1990
University of Pennsylvania, Department of Chemistry. Protein-protein interactions in the complement system.
2/3/1990
Institute for Tropical Diseases, Hamburg, Germany. Protein-protein interactions.
12/14/1989Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions.
12/7/1989
University of Heidelberg, Institute of Immunology, Heidelberg, FRG. The multifunctional role of the third component of complement.
2/2/1989
University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Structure and functions of the third component of complement.
1/20/1989University of Pennsylvania, Department of Pathology and Laboratory Medicine. The complement system as a model system to study protein-protein interactions.
3/24/1988
University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. The multifunctional role of the third component of complement.
2/16/1988Autoimmune Disease Center, Scripps Clinic and Research Foundation, La Jolla. Molecular aspects of the C3 interactions with complement receptors and other complement components.
2/11/1988Molecular Biology Institute, SDSU, San Diego. Molecular aspects of the C3 interactions with complement receptors and other complement components.
2/2/1988
Institute Pasteur, Athens, Greece. The complement system as a model to study protein-protein interactions.
6/11/1987Peptide synthesis Seminar ABI, Basel. Synthetic peptides: A tool to study protein-protein interactions.
6/5/1987
Institute of Molecular Biology, University of Madrid, Spain. The complement system: A model to study protein-protein interactions.
5/15/1987International Titisee Conferences on Proteolytic processing and biological functions. Proteolytic processing of human C3 and its interactions with complement receptors.
4/28/1987
Institute Pasteur, Athens, Greece. The complement system.
1/29/1987Institute of Clinical Immunology, Inselspital, University of Bern. The complement system.
12/17/1986
Department of Biology, Roche, Basel. Molecular interactions in the complement system.
9/19/1986
FEBS Summer School (Advanced course) on Immunological Methods and Applications, Göd, Hungary. Molecular interactions in the complement system.
5/30/1986University of Texas at Houston, M. D. Anderson Hospital, Dept. of Immunology. The multifunctional role of the third component of complement.
12/9/1985
Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Molecular aspects of the C3 interaction with other complement components and complement receptors.
9/16/1985
Basel Institute for Immunology, Basel, Switzerland. Molecular aspects of the C3 interaction with other complement components and complement receptors.
8/27/1985National Institutes of Health/Kidney Disease Section Seminar. Molecular aspects of the C3 interaction with other complement components and complement receptors.
4/9/1985Immunology and Gesellschaft für Immunologie, Lake Balaton, Hungary. 4th Balaton Meeting on "Signals and signal processing in the immune system" Organized by The Hungarian Society for "Molecular aspects of the C3 interaction with CR2, CR3, Factor H and bovine conglutinin".
1/25/1985Aristotelian University of Thessaloniki, Greece, Department of Biology. The use of monoclonal antibodies in Biomedical Sciences.
1/24/1985
Aristotelian University of Thessaloniki, Greece, Department of Biology. The complement system.
10/29/1984
Special workshop on complement receptors, Coconut Grove, Florida. Molecular aspects of the C3 interaction with complement receptors.
2/24/1984University of Ioannina, Greece, Department of Medicine. Interaction of C35 fragments with complement receptors and regulatory proteins.
2/22/1984University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. Mapping of the properdin C5 and C3dR binding sites on the third component of complement.
2/21/1984
University of Heidelberg, Institute of Immunology, Heidelberg, FRG. Interaction of C3 fragments with complement receptors and regulatory proteins.
2/20/1984Johannes-Gutenberg University Institute for Medical Microbiology, Mainz, FRG. Interaction of C3 fragments with complement receptors.
9/15/1981
Duke University Medical Center, Department of Medicine and Pathology. Complement Receptors.
7/13/1981
University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Isolation and characterization of three different complement receptors.